[ad_1]
His company is in line with the United States government on this issue, CEO Daniel O’Day told CBS television on Sunday.
Remdesivir should be available to both patients in the United States and people with a crown in other countries where the drug is allowed.
The United States Food and Drug Administration (FDA) issued an emergency approval Friday for the use of the drug against the new coronavirus-induced lung disease Covid-19. Previously, based on preliminary results, a clinical study showed that remdesivir shortened the recovery time of crown patients. According to the FDA, the drug can be used in adults and children who are hospitalized for severe Covid disease 19.
Gilead chief O’Day said his company will make all of its 1.5 million cans of remdesivir available to the United States government free of charge. This could treat 100,000 to 200,000 patients.
The Washington government will decide on the distribution of the drug in the United States and delivery will begin next week, the Gilead chief announced. A significantly larger amount of the drug will be available in the second half of the year. With more than 66,000 deaths in the crown, the United States is the country most affected by the pandemic worldwide.
Remdesivir, which is injected, invades viruses and prevents them from multiplying. The drug has not yet been officially approved as a drug. The special approval of the American drug agency, however, allows provisional use in the fight against the coronavirus.
Various drugs are being tested to combat the pandemic, including drugs for malaria, hydroxychloroquine, and chloroquine. High pressure vaccines are also being worked on.
